✓ Last verified: March 23, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: East San Jose IV ketamine infusion practice led by a Harvard- and Dartmouth-trained anesthesiologist, focused on outcome-based ketamine therapy for treatment-resistant depression, chronic pain, and severe anxiety.
| Location | San Jose, California |
| Address | 2365 Quimby Rd, Suite 250, San Jose, CA 95122 |
| Phone | (650) 502-4770 |
| Website | kaiaccanesthesia.org |
| Treatments | IV Ketamine |
| Conditions | Treatment-resistant depression, chronic pain, OCD, PTSD, postpartum depression, fibromyalgia, severe anxiety |
| Cost | N/A (contact for pricing) |
| Insurance | IV ketamine is self-pay; FSA/HSA typically eligible with letter of medical necessity |
| KAP Available | No |
| Clinical Lead | Dr. Peter Liang, MD |
HealingMaps Take: KAIA brings ICU-level anesthesia expertise to outpatient ketamine therapy in San Jose. Dr. Peter Liang’s background — dual-boarded in anesthesiology and critical care, with active hospital privileges across the Bay Area — is uncommon in the standalone-infusion-clinic format. Their clinical positioning leans toward medical-model IV ketamine rather than therapy-integrated KAP.
Market Position: KAIA Ketamine Infusion is an IV ketamine specialty clinic in the San Jose / Silicon Valley metro. Cash-pay IV ketamine is the primary access path here; clinicians experienced in critical care monitoring distinguish this practice from generalist infusion centers.
Industry pricing reference. KAIA has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | ✓ Yes |
| Spravato (esketamine) | $0–$250 copay (insured) | — |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Santa Clara County, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
44.9% of patients cite access as the #1 barrier to treatment — the largest single obstacle to ketamine therapy in the HealingMaps corpus, outranking cost, stigma, and side-effect concerns. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
“The team at KAIA brought a level of clinical seriousness I didn’t expect for an outpatient clinic. Dr. Liang reviewed my medication list in detail and explained the dosing approach clearly. The infusion room felt private and monitored, and the recovery period was unhurried.” — patient testimonial, paraphrased from public reviews
KAIA Ketamine Infusion operates from 2365 Quimby Rd in East San Jose, serving Santa Clara County patients seeking IV ketamine therapy for treatment-resistant depression, chronic pain, and severe mood and anxiety disorders. Hours are Monday through Friday, 8am to 6pm.
The clinic is led by Dr. Peter Liang, MD — a Harvard- and Dartmouth-trained anesthesiologist with active critical-care medicine experience across multiple Bay Area hospitals. Dr. Liang is a UCLA cum laude graduate and reportedly scored in the 99th percentile on his anesthesiology boards. The practice describes itself as a multi-disciplinary group of dual-boarded physicians, which is unusual in the standalone-ketamine-infusion-clinic format.
KAIA’s clinical model is medical-first: IV ketamine infusion in a monitored setting, with the protocol calibrated to the patient’s condition. The clinic treats depression, chronic pain, OCD, PTSD, postpartum depression, fibromyalgia, and severe anxiety. Spravato (esketamine) and ketamine-assisted psychotherapy (KAP) are not offered here — patients seeking insurance-covered esketamine or structured therapy integration should look at Bay Area clinics that pair the dosing experience with a licensed therapist.
Pricing is not publicly published; expect cash-pay IV ketamine in the San Jose / Silicon Valley market to run in the $400–$600 per-session range, with FSA / HSA accepted with a letter of medical necessity. Confirm specific pricing, current availability, and intake process by calling (650) 502-4770 or emailing [email protected].
This 5-question summary is matched to the protocols and conditions KAIA treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
KAIA offers IV ketamine infusion as its primary ketamine protocol. The clinic does not currently offer Spravato (esketamine) or formal ketamine-assisted psychotherapy (KAP). Confirm specific dosing schedules and induction series length during your consult.
No — KAIA offers IV ketamine only and does not currently provide Spravato (esketamine). Patients seeking insurance-covered Spravato in the San Jose / Silicon Valley market should evaluate clinics with explicit Spravato REMS certification. Spravato is the FDA-approved esketamine treatment for treatment-resistant depression and is commonly covered by commercial insurance after prior authorization.
KAIA operates a medical-model IV ketamine program rather than a therapy-frame KAP practice. Patients seeking explicit ketamine-assisted psychotherapy with a licensed integration therapist in the San Jose / Silicon Valley market should evaluate clinics that explicitly pair the dosing experience with structured therapy sessions.
KAIA treats depression via IV ketamine (off-label, evidence-based). IV ketamine has the strongest evidence base for rapid relief in treatment-resistant depression among off-label ketamine protocols. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are reasonable candidates here. IV ketamine is cash-pay; patients seeking insurance-covered treatment-resistant depression treatment should also evaluate Spravato-certified clinics.
Yes — KAIA treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which dosing protocol they typically recommend for anxiety-primary patients during your consult.
View all REMS-certified Spravato clinics in California and across the United States.
Leave a Reply